Long-Lived Poxvirus Immunity, Robust CD4 Help, and Better Persistence of CD4 Than CD8 T Cells

Journal of Virology

Volumn 78, Issue 8, 2004, Pages 3811-3816

  Amara, Rama Rao ^a,b   Nigam, Pragati ^a   Sharma, Sunita ^a   Liu, Jinyan ^a   Bostik, Vanda ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; SMALLPOX VACCINE;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LONGITUDINAL STUDY; MEMORY CELL; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TH1 CELL; VACCINIA VIRUS; VIRUS IMMUNITY;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CYTOKINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; LONGITUDINAL STUDIES; SMALLPOX VACCINE; TH1 CELLS; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 1842432621     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.8.3811-3816.2004     Document Type: Article

References (23)

1. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H.-L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
2. Belyakov, I. M., P. Earl, A. Dzutsev, V. A. Kuznetsov, M. Lemon, L. S. Wyatt, J. T. Snyder, J. D. Ahlers, G. Franchini, B. Moss, and J. A. Berzofsky. 2003. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc. Natl. Acad. Sci. USA 100:9458-9463.
3. Bourgeois, C., H. Veiga-Fernandes, A. M. Joret, B. Rocha, and C. Tanchot. 2002. CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 32:2199-2207.
4. Crotty, S., E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed. 2003. SAP is required for generating long-term humoral immunity. Nature 421:282-287.
5. Demkowicz, W. E., Jr., R. A. Littaua, J. Wang, and F. A. Ennis. 1996. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70:2627-2631.
6. + cytotoxic T lymphocytes and interferon gamma-producing T cells after smallpox vaccination. J. Infect. Dis. 185:1657-1659.
7. Enserink, M. 2002. Bioterrorism. In search of a kinder, gentler vaccine. Science 296:1594.
8. Frey, S. E., F. K. Newman, J. Cruz, W. B. Shelton, J. M. Tennant, T. Polach, A. L. Rothman, J. S. Kennedy, M. Wolff, R. B. Belshe, and F. A. Ennis. 2002. Dose-related effects of smallpox vaccine. N. Engl. J. Med. 346:1275-1280.
9. Gani, R., and S. Leach. 2001. Transmission potential of smallpox in contemporary populations. Nature 414:748-751.
10. Hammarlund, E., M. W. Lewis, S. G. Hansen, L. I. Strelow, J. A. Nelson, G. J. Sexton, J. M. Hanifin, and M. K. Slifka. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-1137. (First published 17 August 2003;10.1038/nm917.)
11. Henderson, D. A. 1999. The looming threat of bioterrorism. Science 283:1279-1282.
12. + T lymphocytes. Nature 421:852-856.
13. + cytotoxic T-lymphocyte clones. J. Virol. 66:2274-2280.
14. Mack, T. M., J. Noble, Jr., and D. B. Thomas. 1972. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Med. Hyg. 21:214-218.
15. McHeyzer-Williams, M. G., and R. Ahmed. 1999. B cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 11:172-179.
16. O'Connell, C. J., D. T. Karzon, A. L. Barron, M. E. Plaut, and V. M. Ali. 1964. Progressive vaccinia with normal antibodies: a case possibly due to deficient cellular immunity. Ann. Intern. Med. 60:282-289.
17. Redfield, R. R., D. C. Wright, W. D. James, T. S. Jones, C. Brown, and D. S. Burke. 1987. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 316:673-676.
18. Sarkar, J. K., A. C. Mitra, and M. K. Mukherjee. 1975. The minimum protective level of antibodies in smallpox. Bull. W. H. O. 52:307-311.
19. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-339.
20. + T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining. J. Immunol. Methods 262:167-180.
21. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-342.
22. + T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med. 197:927-932.
23. Weltzin, R., J. Liu, K. V. Pugachev, G. A. Myers, B. Coughlin, P. S. Blum, R. Nichols, C. Johnson, J. Cruz, J. S. Kennedy, F. A. Ennis, and T. P. Monath. 2003. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat. Med. 9:1125-1130.